
Sign up to save your podcasts
Or


In this special episode of GT: The Podcast, made possible with support from Santen Pharmaceuticals, Ike Ahmed, MD; George Durr, MD; and Ticiana De Francesco, MD, share lessons learned on their use of the MicroShunt since its release. Together, they offer pre-operative, intra- operative, and post-operative suggestions, tips for patient selection, proper positioning, and more based on the retrospective clinical studies conducted, in part, by Dr. Durr and Dr. Ahmed.1,2
1. Durr GM, Schlenker MB, Samet S, Ahmed IIK. One-year outcomes of stand-alone ab externo SIBS MicroShunt implantation in refractory glaucoma. Br J Ophthalmol. 2020. Available at: bjophthalmol-2020-317299. Epub ahead of print.
2. Schlenker MB, Durr GM, Michaelov E, Ahmed IIK. Intermediate outcomes of a novel standalone ab externo SIBS MicroShunt with mitomycin c. Am J Ophthalmol. 2020;215:141-153.
By Glaucoma Today5
1010 ratings
In this special episode of GT: The Podcast, made possible with support from Santen Pharmaceuticals, Ike Ahmed, MD; George Durr, MD; and Ticiana De Francesco, MD, share lessons learned on their use of the MicroShunt since its release. Together, they offer pre-operative, intra- operative, and post-operative suggestions, tips for patient selection, proper positioning, and more based on the retrospective clinical studies conducted, in part, by Dr. Durr and Dr. Ahmed.1,2
1. Durr GM, Schlenker MB, Samet S, Ahmed IIK. One-year outcomes of stand-alone ab externo SIBS MicroShunt implantation in refractory glaucoma. Br J Ophthalmol. 2020. Available at: bjophthalmol-2020-317299. Epub ahead of print.
2. Schlenker MB, Durr GM, Michaelov E, Ahmed IIK. Intermediate outcomes of a novel standalone ab externo SIBS MicroShunt with mitomycin c. Am J Ophthalmol. 2020;215:141-153.

91,097 Listeners

43 Listeners

18 Listeners

97 Listeners

112,574 Listeners

8,995 Listeners

159 Listeners

8 Listeners

11 Listeners

10 Listeners

52 Listeners

10 Listeners

16 Listeners

18 Listeners

0 Listeners